NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I don't believe a PR is assured by any means, if they had a partner, and if that partner paid a milestone payment when the trial were unblinded, it would be PR'd as a material event. They will receive no funds for unblinding, or anything else they do, actually including the act of releasing TLD, but that's what TLD is, the release of a summary of what is seen when the trial is unblinded, as well as an assessment of the way forward.

I believe they should be submitting a placeholder Abstract for SNO which hopefully can be replaced by the TLD. At SNO I believe we'll get the comprehensive data for the trial.

Of course we don't know if SNO will be a live or virtual or live conference this year, but either way, a presentation is considered to be peer review, so after it the full data can be shared with investors.

Gary